No Data
No Data
No Data
No Data
No Data
Otonomy (NASDAQ:OTIC) Research Coverage Started at StockNews.com
Research analysts at StockNews.com started coverage on shares of Otonomy (NASDAQ:OTIC – Get Rating) in a research report issued to clients and investors on Monday. The firm set a "hold" rating on the
Defense WorldMay 1, 2023 13:23
Otonomy (NASDAQ:OTIC) Now Covered by StockNews.com
Equities research analysts at StockNews.com assumed coverage on shares of Otonomy (NASDAQ:OTIC – Get Rating) in a note issued to investors on Wednesday. The firm set a "hold" rating on the biopharmace
Defense WorldMar 22, 2023 13:17
Olema Pharmaceuticals (NASDAQ:OLMA) and Otonomy (NASDAQ:OTIC) Critical Comparison
Olema Pharmaceuticals (NASDAQ:OLMA – Get Rating) and Otonomy (NASDAQ:OTIC – Get Rating) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based
Defense WorldMar 13, 2023 13:54
Requisite Capital Management LLC Acquires Shares of 150,000 Otonomy, Inc. (NASDAQ:OTIC)
Requisite Capital Management LLC acquired a new stake in Otonomy, Inc. (NASDAQ:OTIC – Get Rating) in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Ex
Financial News LiveMar 13, 2023 01:03
StockNews.com Initiates Coverage on Otonomy (NASDAQ:OTIC)
StockNews.com began coverage on shares of Otonomy (NASDAQ:OTIC – Get Rating) in a research report sent to investors on Saturday morning. The firm issued a hold rating on the biopharmaceutical company'
kopsourceFeb 22, 2023 14:52
Otonomy (NASDAQ:OTIC) Stock Passes Below 200-Day Moving Average of $0.32
Otonomy, Inc. (NASDAQ:OTIC – Get Rating)'s share price crossed below its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of $0.32 and traded as low as $0.1
Financial News LiveFeb 4, 2023 09:21
No Data
No Data